Institution: | 1. National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA;2. Centre Hospitalier, de l''Université de Montreal (CHUM), Montreal, Quebec, Canada;3. The University of Texas M. D. Anderson Cancer Center, Houston;4. International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium;5. University of Pittsburgh Cancer Institute, PA;6. Institut Curie, Paris, France;7. Colorado Cancer Research Program, Denver, CO;8. Joe Arrington Cancer Research and Treatment Center, Lubbock, TX;9. Albert Einstein Healthcare Network, Philadelphia, PA;10. Kaiser Permenente Vallejo, Vallejo, CA;11. Allegheny General Hospital, Pittsburgh, PA;12. Aultman Health Foundation, Canton, OH;1. Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands;2. Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands;3. Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands;4. Department of Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands;5. Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, Netherlands;6. Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, Netherlands;7. Department of Medical Oncology, Isala, Zwolle, Netherlands;8. Department of Medical Oncology, Maxima Medical Center, Eindhoven, Netherlands;9. Department of Medical Oncology, VieCuri Medical Center, Venlo, Netherlands;10. Department of Medical Oncology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands;11. Department of Medical Oncology, Catharina Cancer Centre, Eindhoven, Netherlands;12. Department of Pathology, University Medical Centre, Utrecht, Netherlands;1. Department of Medical Oncology, Centre Georges-Francois Leclerc, Dijon, France;2. Department of Pathology, Centre Georges-Francois Leclerc, Dijon, France;3. Department of Nuclear Medicine, Centre Georges-Francois Leclerc, Dijon, France;4. Department of Medical Oncology, Institut Curie, Université Paris Descartes, Paris, France;5. Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, France;6. Department of Nuclear Medicine, Hopital Tenon, Paris, France;7. Department of Medical Oncology, Centre Antoine-Lacassagne, Nice, France;8. Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France;9. Department of Medical Oncology, Centre Eugène Marquis, Rennes, France;10. Department of Medical Oncology, Centre Hospitalier Universitaire Augustin-Morvan, Brest, France;11. Department of Medical Oncology et Unité INSERM U590, Centre Léon Berard, Lyon, France;12. Department of Surgery, Institut Daniel Hollard, Grenoble, France;13. Department of Surgery, Centre Oscar Lambret, Lille, France;14. Department of Medical Oncology, Clinique Hartmann, Neuilly sur Seine, France;15. Department of Medical Oncology, CHU Bretonneau, Tours, France;p. Department of Medical Oncology, Centre Pierre Curie, Beuvry, France;q. Université François-Rabelais de Tours, CNRS, GICC UMR 7292, CHRU de Tours, Laboratory of Pharmacology-Toxicology, Tours, France;r. Immunology Department, CHU Bretonneau, Tours, France;s. Roche Laboratory, Boulogne Billancourt, France;t. Experis IT, Nanterre, France;1. German Breast Group, Neu-Isenburg, Germany;2. Divisione di Senologia Medica, Division of Medical Senology, Milan, Italy;3. Marienhospital Bottrop, Klinik fur Gynakologie und Geburtshilfe, Bottrop, Germany;4. Hospital Universitario Arnau de Vilanova, Lleida, Spain;5. Centro de Estudos de Hematologia e Oncologia, Sao Paulo, Brazil;6. Institute for Oncology and Radiology of Serbia, Belgrade, Serbia;7. Amgen, Thousand Oaks, CA, USA;1. Universidade Federal de São Paulo, Departamento de Microbiologia, Imunologia e Parasitologia, campus São Paulo, Brazil;2. Universidade Paulista, campus São Paulo, Brazil;3. Universidade Federal de São Paulo, Departamento de Ciências Biológicas, campus Diadema, Brazil;4. Universidade Federal de São Paulo, Departamento de Medicina, campus São Paulo, Brazil;1. National Center for Tumor Diseases, University Hospital, Heidelberg, Germany;2. British Columbia Cancer Agency – Vancouver Centre, University of British Columbia, Vancouver, Canada;3. Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK;4. Regional Cancer and Blood Services, Auckland City Hospital, Auckland, New Zealand;5. Cancer Institute “Ion Chiricuta”, Cluj-Napoca, Romania;6. Clinical Science, Global Product Development, Roche Products Limited, Welwyn Garden City, UK;7. Product Development – Oncology, Genentech, Inc., South San Francisco, CA, USA;8. PDBB – Biostatistics, Roche Products Limited, Welwyn Garden City, UK;9. Ramón y Cajal University Hospital, Madrid and Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain;1. Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Freiburg, Germany;2. Department of Obstetrics and Gynecology, University Medical Center – Rheinisch-Westfälische Technische Hochschule, Aachen, Germany;3. Institute for Medical Biometry and Statistics, Medical Center - University of Freiburg, Freiburg, Germany;4. Department of Surgery, Medical Center - University of Freiburg, Freiburg, Germany;5. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany |